Literature DB >> 1639336

Catheter ablation of ventricular tachycardia using radiofrequency current.

M Borggrefe1, S Willems, X Chen, G Hindricks, W Haverkamp, A Martinez-Rubio, C Hief, M Shenasa, G Breithardt.   

Abstract

Catheter ablation techniques have evolved as an alternative to map-guided surgery and proven effective in a variety of supraventricular tachyarrhythmias. Direct current catheter ablation has been shown to be effective in about 50 to 70% of cases. Approximately, 60% of patients with structural heart disease and monomorphic ventricular tachycardia were successfully treated using direct current ablation techniques. This overall success rate and possible risks associated with the use of direct current have stimulated the search for other energy sources appropriate for catheter ablation. Presently, only a few preliminary reports on the clinical efficacy of radiofrequency energy for the treatment of ventricular tachyarrhythmias in man exist. 23 patients with identifiable heart disease at a mean age of 52 +/- 17 years underwent radiofrequency catheter ablation. 16 patients had coronary artery disease, one patient dilative cardiomyopathy and six patients had arrhythmogenic right ventricular disease. All patients presented with chronic current sustained ventricular tachycardia. After detailed endocardial catheter mapping radiofrequency energy was applied at the site of earliest ventricular activation during ventricular tachycardia which could be entrained during fixed rate ventricular pacing at the site of origin of ventricular tachycardia. At all ablation sites a long latency between the stimulus and QRS complex was noted. Of 23 patients 18 were treated with radiofrequency alone whereas in five patients a second ablation procedure using direct current was performed. Following the ablation procedures, 14 patients (61%) remained free of ventricular tachycardia. One patient died due to congestive heart failure 21 months following ablation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1639336

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  6 in total

Review 1.  Deciphering cryptic proteases.

Authors:  M A Liz; M M Sousa
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

2.  Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience.

Authors:  G Fontaine; J Tonet; Y Gallais; G Lascault; F Hidden-Lucet; P Aouate; F Halimi; F Poulain; N Johnson; H Charfeddine; R Frank
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 3.  Radiofrequency catheter ablation: a new frontier in interventional cardiology.

Authors:  Y Bashir; D E Ward
Journal:  Br Heart J       Date:  1994-02

Review 4.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

Review 5.  [Catheter ablation of ventricular tachycardia : What have we achieved?]

Authors:  T Konrad; B A Hoffmann; T Rostock
Journal:  Herz       Date:  2017-04       Impact factor: 1.443

6.  Role of catheter ablation in arrhythmogenic right ventricular dysplasia.

Authors:  Johnson Francis; Guy Fontaine
Journal:  Indian Pacing Electrophysiol J       Date:  2005-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.